Petrus Trust Company, Lta Cerus Corp Transaction History

Petrus Trust Company, Lta

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.41 - $5.69 $50,348 - $64,962	-11,417 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.81 - $6.99 $54,915 - $79,804	11,417 New	11,417 $63,000
Q1 2021 May 17, 2021	SELL	$5.68 - $7.87 $62,258 - $86,263	-10,961 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.25 - $8.56 $57,545 - $93,826	10,961 New	10,961 $76,000
Q4 2018 Feb 14, 2019	SELL	$4.89 - $7.16 $146,445 - $214,427	-29,948 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.89 - $7.78 $206,341 - $232,995	29,948 New	29,948 $216,000

155

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $273M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

Stay updated on Petrus Trust Company, Lta with notifications on news.